Halozyme Therapeutics Inc. Common Stock vs Life Time Group Holdings Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B), while Life Time Group Holdings Inc. Common Stock trades at $40.13 (market cap $9.00B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Life Time Group Holdings Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Life Time Group Holdings Inc. Common Stock for 0 Days on average.
| HALO | LTH | |
|---|---|---|
Market Cap | $12.58B | $9.00B |
Volume | 2,179,278 | 2,696,923 |
Sector | Health | Consumer Cyclical |
52-Week High | $115.22 | $45.73 |
52-Week Low | $61.63 | $24.59 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $13.05B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Life Time operates fitness and lifestyle centers that offer gyms, classes, sports facilities, and wellness services.
Read more on LTH →